Coordinating Committee

Initial steps to establish the Enterprise were undertaken by a self-appointed Steering Committee. This committee was subsequently replaced by a Coordinating Committee which has been the primary body responsible for setting the strategic direction of the Enterprise in conjunction with the interim Secretariat.

Current Coordinating Committee members include:

  • Seth Berkley
    International AIDS Vaccine Initiative, U.S.
  • M.K. Bhan
    Ministry of Science & Technology, India
  • Michel De Wilde
    Sanofi-Pasteur, France
  • José Esparza (Head of the interim Secretariat)
    Bill & Melinda Gates Foundation, US
  • Anthony Fauci
    National Institutes of Health, U.S.
  • Helene Gayle
  • Catherine Hankins
    Joint United Nations Programme on HIV/AIDS
  • Margaret Johnston
    National Institutes of Health, U.S.
  • Pontiano Kaleebu
    African AIDS Vaccine Programme, Uganda
  • Edward Karamov
    Institute of Virology, Russia
  • Eric Lander
    Broad Institute of MIT and Harvard University, U.S.
  • Malegapuru William Makgoba
    University of KwaZulu-Natal, South Africa
  • Pascoal Mocumbi
    European and Developing Countries Clinical Trials Partnership, E.U.
  • Octavi Quintana Trias
    European Commission, E.U.
  • Rino Rappuoli
    Chiron Corporation, Italy
  • William Snow
    AIDS Vaccine Advocacy Coalition, U.S.
  • Mark Walport
    Wellcome Trust, U.K.
All Content ©2005 - 2008 Global HIV Vaccine Enterprise